The estimated Net Worth of Joseph Eid is at least $910 Thousand dollars as of 3 June 2021. Mr. Eid owns over 2,154 units of Bristol-Myers Squibb Co stock worth over $496,736 and over the last 5 years he sold BMY stock worth over $413,598. In addition, he makes $0 as Senior Vice President and Head of Global Medical Affairs Member of the Leadership Team at Bristol-Myers Squibb Co.
Joseph has made over 8 trades of the Bristol-Myers Squibb Co stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 2,154 units of BMY stock worth $104,663 on 3 June 2021.
The largest trade he's ever made was exercising 6,134 units of Bristol-Myers Squibb Co stock on 10 March 2021 worth over $298,051. On average, Joseph trades about 3,014 units every 69 days since 2019. As of 3 June 2021 he still owns at least 10,223 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Eid stock trades at the bottom of the page.
Joseph Eid serves as Senior Vice President and Head of Global Medical Affairs Member of the Leadership Team of the Company. 2014 to 2017 – Vice President, Head of Oncology Global Medical Affairs, Merck 2017 to 2019 – Head of Global Medical 2017 to present – Senior Vice President and Head of Global Medical Affairs
Joseph Eid is 52, he's been the Senior Vice President and Head of Global Medical Affairs Member of the Leadership Team of Bristol-Myers Squibb Co since 2017. There are 28 older and 7 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Joseph's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 430 E. 29TH STREET, 14TH FLOOR, NEW YORK, NY, 10016.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: